FDA jumps on another Mylan plant in India, slapping it with a warning letter
The FDA has issued a warning letter to another Mylan plant in India for ongoing data integrity issues. In the letter, the agency said investigators continued to find issues with batch testing results disappearing from computers when failed tests were involved.
No comments:
Post a Comment